Join the Hepatitis C group to help and get support from people like you.
Hepatitis C News (Page 4)
Related terms: Hepatitis C, Chronic, Chronic Hepatitis C, Hep C
FDA Approves Olysio (simeprevir) in Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C Infection
TITUSVILLE, N.J., Nov. 5, 2014 /PRNewswire/ – Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved Olysio (simeprevir),...
FDA Approves Harvoni (ledipasvir and sofosbuvir) for Hepatitis C
October 10, 2014 – The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first...
FDA Approves Sovaldi for Chronic Hepatitis C
December 6, 2013 – The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated...
FDA Approves Olysio (simeprevir) for Hepatitis C Virus
November 22, 2013 – The U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Hepatitis C is a viral disease that causes...
FDA Medwatch Alert: Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
ISSUE: FDA received reports of serious skin reactions, some fatal, in patients taking the hepatitis C drug Incivek (telaprevir) in combination with the drugs peginterferon alfa and ribavirin (Incivek...
FDA Approves New Indication for Promacta (eltrombopag)
LONDON, Nov. 19, 2012 – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Promacta for the treatment of thrombocytopenia (low blood platelet counts)...
FDA Medwatch Alert: Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions
[UPDATED 04/26/2012] FDA notified healthcare professionals that the Victrelis drug label has been revised to state that co-administration of Victrelis (boceprevir), a hepatitis C virus (HCV) protease...
FDA Approves Incivek (telaprevir) for People with Hepatitis C
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved Incivek (telaprevir) tablets for a broad group...
FDA Approves Merck's Victrelis (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor
WHITEHOUSE STATION, N.J., May 13, 2011 – Merck (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved Victrelis (...
Ask a question
To post your own question to this support group, sign in or create an account.